Receptor Mediated Glycotargeting

References

• Adam A., Petit J. F., Lefrancier P., Lederer E. Muramyl peptides: chemical structure, biological activity and mechanism of action. Mol. Cell. Biochem. (1981); 41: 27–47
   PubMed Web of Science ®Google Scholar
• Ambler L., Hudson A. M. Pharmacokinetics and metabolism of muramyl dipeptide and nor-muramyl dipeptide [3H-labelled] in the mouse. Int. J. Immunopharmacol (1984); 6: 133–139
   PubMed Web of Science ®Google Scholar
• Anderson W. F. Human gene therapy. Science (1992); 256: 808–813
   PubMed Web of Science ®Google Scholar
• Arsequell G., Dwek R. A., Wong S. Y.C. 9-Fluorenylmethoxycarbonyl (Fmoc)-glycine coupling of sac-charideβ-glycosylamines for the fractionation of oligosaccharides and the formation of neoglycoconjugates. Anal. Biochem. (1994); 216: 165–170
   PubMed Web of Science ®Google Scholar
• Ashwell G., Harford J. Carbohydrate specific receptors of the liver. Annu. Rev. Biochem. (1982); 51: 531–554
   PubMed Web of Science ®Google Scholar
• Balboni P. G., Minia A., Grossi M. P., Barbanti-Brodano G., Mattioli A., Fiume L. Activity of albumin conjugates of 5-fluorodeoxyuridine and cytosine arabinoside on poxviruses as a lysosomotropic approach to antiviral chemotherapy. Nature (1976); 264: 181–183
   PubMed Web of Science ®Google Scholar
• Barranger J. A. Gaucher's disease: new hope for treatment. Lancet (1993); 342: 1372
   PubMed Web of Science ®Google Scholar
• Barratt G., Tenu J., Yapo A., Petit J. Preparation and characterization of liposomes containing mannosylated phospholipids capable of targeting drugs to macrophages. Biochem. Biophys. Acta (1986); 862: 153–164
   Google Scholar
• Barton N. W., Brady R. O., Dambrosia J. M., Bisceglie A. M., Doppelt S. H., Hill S. C., Mankin H. J., Murray G. J., Parker R. I., Agroff C. E., Grewal R. P., Yu K., collaborates. Replacement therapy for inherited enzyme deficiency -macrophage targeted glucocerebrosidase for gaucher's disease. New Engl. J. Med. (1991); 324: 1464–1470
   PubMed Web of Science ®Google Scholar
• Beutler E. Gaucher's disease: new molecular approaches to diagnosis and treatment. Science (1992); 256: 794–799
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Stengelin S., Gimbrowne M. A., Jr., Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989); 243: 1160–1165
   PubMed Web of Science ®Google Scholar
• Bijsterbosch M. K., Ziere G. J., Van Berkel T. J.C. Lactosylated low density lipoprotein: a potential site-specific delivery of drugs to Kupffer cells. Molecular Pharmacol. (1989); 36: 484–486
   PubMed Web of Science ®Google Scholar
• Bijsterbosch M. K., Van Berkel T. J.C. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver. Biochem. J. (1990); 270: 233–239
   PubMed Web of Science ®Google Scholar
• Bonfils E., Depierreux C., Midoux P., Thuong N. T., Monsigny M., Roche A. C. Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates. Nucleic Acids Res. (1992a); 20: 4621–4629
   PubMed Web of Science ®Google Scholar
• Bonfils E., Mendes C., Roche A. C., Monsigny M., Midoux P. Uptake by macrophages of a biotinylated oligo-α-deoxythymidylate by using mannosylated streptavidin. Bioconjugate Chem. (1992b); 3: 277–284
   PubMed Web of Science ®Google Scholar
• Brady R. O., Barranger J. A. The Metabolic Basis of Inherited Disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Frederickson, J. L. Goldstein, M. S. Brown. McGraw-Hill, New York (1983); 842–856
   Google Scholar
• Brady R. O. The Molecular Basis of Lysosomal Storage Disorders, J. A. Barranger, R. O. Brady. Academic Press, Orlando, FL (1984); 461–478
   Google Scholar
• Breton P., Midoux P., Petit C., Bousser M., Roche A. C., Mayer R., Monsigny M. Production of macrophage-derived cytotoxic factor by N-[3](carbamoylmethyl) thio] propionylated) neoglycoproteins. Bioconjugate Chem. (1991); 2: 16–18
   PubMed Web of Science ®Google Scholar
• Brinkley M. A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. Bioconjugate Chem. (1992); 3: 2–13
   PubMed Web of Science ®Google Scholar
• Budker V. G., Knorre D. G., Vlassov V. V. Cell membranes as barriers for antisense constructions. Antisense Research Development (1992); 2: 177–184
   PubMedGoogle Scholar
• Bundgaard H. Design of prodrugs: bioreversible derivatives for various functional groups and chemical entities. Design of Prodrugs, H. Bundgaard. Elsevier, Amsterdam (1985); 1–92
   Google Scholar
• Bunnell B. A., Askari F. A., Wilson J. M. Targeted delivery of antisense oligonucleotides by molecular conjugates. Somatic Cell Molecular Genetics (1992); 18: 559–569
   PubMedGoogle Scholar
• Canonico P. G., Kende M., Gabrielson B. Carrier-mediated delivery of antiviral agents. Advances in Virus Research, K. Maramorosch, F. A. Murphy, A. J. Shatkin. Academic Press, New York (1988); 271–312
   Google Scholar
• Chiu M., Tamura T., Wadhwa M. S., Rice K. G. In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetyl-galactosamine residues. J. Biol. Chem. (1994); 269: 16195–16202
   PubMed Web of Science ®Google Scholar
• Cohen J. S. Oligonucleotides as therapeutic agents. Pharmacol. Ther. (1991); 52: 211–225
   PubMed Web of Science ®Google Scholar
• Cristiano R. J., Smith L. C., Woo S. L.C. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. USA (1993); 90: 2122–2126
   PubMed Web of Science ®Google Scholar
• Curtis B. M., Scharnowske S., Watson A. J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelop glycoprotein gpl20. Proc. Natl. Acad. Sci. USA (1992); 89: 8356–8360
   PubMed Web of Science ®Google Scholar
• Das P. K., Murray G. J., Zirzow G. C., Brady R. O., Barranger J. A. Lectin-specific targeting of beta-glucocerebrosidase to different liver cells via glycosylated liposomes. Biochemical Medicine (1985); 33: 124–131
   PubMed Web of Science ®Google Scholar
• De Smidt P. C., Van Berkel T. J. LDL-mediated drug-targeting. Crit. Rev. Ther. Drug Carrier Sys. (1990); 7: 99–120
   PubMed Web of Science ®Google Scholar
• De Clercq E. Targets and strategies for the antiviral chemotherapy of AIDS. TIPS (1990); 11: 198–205
   PubMed Web of Science ®Google Scholar
• Derrien D., Midoux P., Petit C., Negre E., Mayer R., Monsigny M., Roche A. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators. Glycoconjugate J. (1989); 6: 241–255
   PubMed Web of Science ®Google Scholar
• Doebber T. W., Wu M. S., Bugianesi R. L., Ponpipom M. M., Furbish F. S., Barranger J. A., Brady R. O., Shen T. Y. Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase. J. Biol. Chem. (1982); 257: 2193–2199
   PubMed Web of Science ®Google Scholar
• Drickamer K. Two distinct classes of carbohydrate-recognition domains in animal lectins. J. Biol. Chem. (1988); 263: 9557–9560
   PubMed Web of Science ®Google Scholar
• Drickamer K. Ca+2-dependent carbohydrate-recognition domains in animal proteins. Curr. Opin. Struc. Biol (1993); 3: 393–400
   Web of Science ®Google Scholar
• Drickamer K. Recognition of complex carbohydrates by Ca2+-dependent animal lectins. Biochemical Society Transactions (1993); 21: 456–459
   PubMed Web of Science ®Google Scholar
• Duncan R., Cable H. C., Lloyd J. B., Rejmanova P., Kopecek J. Polymers containing enzymatically degradable bonds: 7. Design of oligopeptide side chains in poly N-(2-hydroxypropyl)methacrylamide copolymers to promote efficient degradation by lysosomal enzymes. Makromol. Chem. (1983); 184: 1997–2008
   Web of Science ®Google Scholar
• Duncan R., Hume I. C., Kopeckova P., Ulbrich K., Strohalm J., Kopecek J. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo. J. Controlled Release (1989); 10: 51–63
   Web of Science ®Google Scholar
• Ehrlich P. Collected Studies on Immunity. Wiley, New York (1906); 442–447
   Google Scholar
• Evans R., Alexander P. Mechanism of immunologically specific killing of tumor cells by macrophages. Nature (1972); 236: 168–170
   PubMed Web of Science ®Google Scholar
• Ezekowitz R. A.B., Kuhlman M., Groopman J. E., Byrn R. A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. (1989); 169: 185–196
   PubMed Web of Science ®Google Scholar
• Fidler I. J., Poste G. Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease. Springer Semin. Immunopathol. (1982); 5: 161–174
   PubMed Web of Science ®Google Scholar
• Fidler I. J. Macrophages and metastasis - a biological approach to cancer therapy. Cancer Res. (1985); 45: 4714–4726
   PubMed Web of Science ®Google Scholar
• Figueroa M. L., Rosenbloom B. E., Kay A. C., Garver P., Thurston D. W., Koziol J. A., Gelbart T., Beutler E. A less costly regimen of alglucerase to treat Gaucher's disease. New Engl. J. Med. (1992); 327: 1632–1636
   PubMed Web of Science ®Google Scholar
• Fiume L., Mattioli A., Busi C., Balboni P. G., Barbanti-Brodano G., De Vries J., Altmann R., Weiland Th. Selective inhibition of ectromelia virus DNA synthesis in hepatocytes by adenine-9-β-D-arabinofuranoside (ARA-A) and adenine-9-β-D-arabinofuranoside 5′-monophosphate (ARA-AMP) conjugated to asialofetuin. FEBS Letts. (1980); 116: 185–188
   PubMed Web of Science ®Google Scholar
• Fiume L., Bassi B., Busi C., Mattioli A., Spinosa G., Faulstich H. Galactosylated poly(L-lysine) as a hepatotropic carrier of 9-β-D-arabinofuranosyladenine 5′-monophosphate. FEBS (1986a); 203: 203–206
   PubMed Web of Science ®Google Scholar
• Fiume L., Bassi B., Busi C., Mattioli A., Spinosa G. Drug targeting in antiviral chemotherapy: a chemically stable conjugate of 9-β-D-arabinofuranosyl-adenine 5′-monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells. Biochem. Pharmacol (1986b); 35: 967–972
   PubMed Web of Science ®Google Scholar
• Fiume L., Busi C., Preti P., Spinosa G. Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat. Cancer Drug Delivery (1987a); 4: 145–150
   PubMedGoogle Scholar
• Fiume L., Mattioli A., Spinosa G. Distribution of a conjugate of 9-β-D-arabinofuranosyladenine 5′-monophosphate (ara-AMP) with lactosaminated albumin in parenchymal and sinusoidal cells of rat liver. Cancer Drug Delivery (1987b); 4: 11–16
   PubMedGoogle Scholar
• Fiume L., Cerenzia M. R.T., Bonino F., Busi C., Mattioli A., Brunetto M. R., Chiaberge E., Verme G. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. Lancet (1988); 2: 13–15
   PubMed Web of Science ®Google Scholar
• Fiume L., Stefano G. D., Busi C., Mattioli A. A conjugate of lactosaminated poly-l-lysine with adenine arabinoside monophosphate, administered to mice by intramuscular route, accomplishes a selective delivery of the drug to the liver. Biochem. Pharmacol (1994); 47: 643–650
   PubMed Web of Science ®Google Scholar
• Franssen E. J.F., Van Amsterdam R. G.M., Visser J., Moolenaar F., De Zeeuw D., Meijer D. K.F. Low molecular weight proteins as carriers for renal drug targeting: naproxenlysozyme. Pharm. Res. (1991); 8: 1223–1230
   PubMed Web of Science ®Google Scholar
• Franssen E. J.F., Jansen R. W., Vaalburg M., Meijer D. K.F. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules. Biochem. Pharmacol (1993); 45: 1215–1226
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical: an endogenous toxicant. Ann. Rev. Pharmacol (1983); 23: 239–257
   Google Scholar
• Fujita T., Nishikawa M., Tamaki C., Takakura Y., Hashida M., Sezaki H. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono-and polysaccharide derivatives. J. Pharmacol. Exp. Ther. (1992); 263: 971–978
   PubMed Web of Science ®Google Scholar
• Furbish F. S., Steer C. J., Barranger J. A., Jones E. A., Brady R. O. The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and kupffer cells. Biochem. Biophys. Res. Commun. (1978); 81: 1047–1053
   PubMed Web of Science ®Google Scholar
• Furbish F. S., Steer C. J., Krett N. L., Barranger J. A. Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation. Biochim. Biophys. Acta (1981); 673: 425–434
   PubMed Web of Science ®Google Scholar
• Gabius H. J., Bardosi A. Neoglycoproteins as tools in glycohistochemistry. Prog. Histochem. Cytochem. (1991); 22: 1–16
   PubMed Web of Science ®Google Scholar
• Gattegno L., Ramdani A., Jouault T., Saffar L., Gluckman J. C. Lectincarbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). AIDS Research Human Retroviruses (1992); 8: 27–37
   PubMed Web of Science ®Google Scholar
• Ghose T., Blair A. H., Kulkarni P. N. Preparation of antibody-linked cytotoxic agents. Meth. Enzymol (1983); 93: 280–333
   PubMed Web of Science ®Google Scholar
• Ghose T., Blair A. H. The design of cytotoxic-agent-antibody conjugates. CRC Crit. Rev. Therap. Drug Carrier Sys. (1987); 3: 263–359
   PubMed Web of Science ®Google Scholar
• Ghosh P., Bachhawat B. K. Grafting of different glycosides on the surface of liposomes and its effect on the tissue distribution of 125I-labelled globulin encapsulated in liposomes. Biochim. Biophys. Acta. (1980); 632: 562–572
   PubMed Web of Science ®Google Scholar
• Ghosh M. K., Cohen J. S. Oligodeoxynucleotides as antisense inhibitors of gene expression. Prog. Nucleic Acid Res. Mol. Biol (1992); 42: 79–126
   PubMed Web of Science ®Google Scholar
• Greenfield R. S., Kaneko T., Daues A., Edson M. A., Fitzgerald K. A., Olech L. J., Grattan J. A., Spitalny G. L., Braslawsky G. R. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res. (1990); 50: 6600–6607
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Targeting of drugs. Nature (1977); 265: 407–411
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Targeting of drugs with molecules, cells and liposomes. TIPS (1983); 4: 304–307
   Web of Science ®Google Scholar
• Gregoriadis G., Florence A. T. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs (1993); 45: 15–28
   PubMed Web of Science ®Google Scholar
• Haensler J., Szoka F. C., Jr. Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. Bioconjugate Chem. (1993); 4: 85–93
   PubMed Web of Science ®Google Scholar
• Hara T., Aramaki Y., Tsuchiya S., Hosoi K., Okada A. Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein. Biopharm. Drug Dispos. (1987); 8: 327–339
   PubMed Web of Science ®Google Scholar
• Hirabayashi J. A general comparison of two major families of animal lectins. Trends Glycoscience Glycotechnology (1993); 5: 251–270
   Google Scholar
• Hofsteenge J., Capuano A., Altszuler R., Moore S. Carrier-linked primaquine in the chemotherapy of malaria. J. Med. Chem. (1986); 29: 1765–1769
   PubMed Web of Science ®Google Scholar
• Hoppe C. A., Lee Y. C. The binding and processing of mannose-bovine serum albumin derivatives by rabbit alveolar macrophages. Effect of the sugar density. J. Biol. Chem. (1983); 258: 14193–14199
   PubMedGoogle Scholar
• Hoyle G. W., Hill R. L. Molecular cloning and sequencing of a cDNA for a carbohydrate binding receptor unique to rat kupffer cells. J. Biol. Chem. (1988); 263: 7487–7492
   PubMed Web of Science ®Google Scholar
• Li M., Kurata H., Itoh N., Yamashina I., Kwwasaki T. Molecular cloning and sequence analysis of cDNA encoding the macrophage lectin specific for galactose and N-acetyl-galactosamine. J. Biol. Chem. (1990); 265: 11295–11298
   PubMed Web of Science ®Google Scholar
• Ishihara H., Hara T., Aramaki Y., Tsuchiya S., Hosoi K. Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-γ and their uptake by isolated rat hepatocytes. Pharm. Res. (1990); 7: 542–546
   PubMed Web of Science ®Google Scholar
• Jansen R. W., Molema G., Pauwels R., Schols D., De Clercq E., Meijer D. K.F. Potent in vitro anti-human immunodeficiency virus-1 activity and modified human serum albumins. Molecular Pharmacol. (1991); 39: 818–823
   PubMed Web of Science ®Google Scholar
• Jansen R. W., Kruijt J. K., Van Berkel T. J.C., Meijer D. K.F. Coupling of the antiviral drug ara-AMP to lactosaminated albumin leads to specific uptake in rat and human hepatocytes. Hepatology (1993); 18: 146–152
   PubMed Web of Science ®Google Scholar
• Johnston G. I., Cook R. G., McEver R. P. Cloning of GMP-140, a granule membrane protein of platelets and endothelium:sequence similarity to proteins involved in cell adhesion and inflammation. Cell (1989); 56: 1033–1044
   PubMed Web of Science ®Google Scholar
• Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science (1989); 243: 375–378
   PubMed Web of Science ®Google Scholar
• Karlsson K. A. Glycobiology: a growing field for drug design. TIPS (1991); 12: 265–272
   PubMed Web of Science ®Google Scholar
• Kempen H. J.M., Hoes C., Van Boom J. H., Spanjer H. H., De Lange J., Langendoen A., Van Berkel T. J.C. A water-soluble cholesteryl-containing trisgalactoside: synthesis, properties, and use in directing lipid-containing particles to the liver. J. Med. Chem. (1984); 27: 1306–1312
   PubMed Web of Science ®Google Scholar
• Kikutani H., Inui S., Sata R., Barsumian E. L., Owaki H., Yanasaki K., Kaisho T., Uchibayashi N., Harddy R. R., Hirano T., Tsunasawa S., Sakiyama F., Suenura F., Suemura M., Kishimoto T. Molecular structure of human lymphocyte receptor for immunoglobulin E. Cell (1986); 47: 657–665
   PubMed Web of Science ®Google Scholar
• Kirsh R., Bugelski P. J., Poste G. Drug delivery to macrophages for the therapy of cancer and infectious diseases. Annals N.Y. Acad. Sci. (1987); 507: 141–154
   PubMed Web of Science ®Google Scholar
• Kopecek J., Duncan R. Targetable polymeric prodrugs. J. Controlled Release (1987); 6: 315–327
   Google Scholar
• Kopecek J. Targetable polymeric anticancer drugs. Temporal control of drug activity. Ann. N.Y. Acad. Sci. (1991); 618: 335–344
   PubMed Web of Science ®Google Scholar
• Koppel G. A. Recent advances with monoclonal antibody drug targeting for the treatment of human cancer. Bioconjugate Chem. (1990); 1: 13–23
   PubMed Web of Science ®Google Scholar
• Kosmas C., Linardou H., Epenetos A. Review: advances in monoclonal antibody tumour targeting. J. Drug Targeting (1993); 1: 81–91
   PubMed Web of Science ®Google Scholar
• Lasky L. A., Singer M. S., Yednock T. A., Dowbendo D., Fennie C., Rodriguez H., Nguyen T., Stachel S., Rosen S. D. Cloning of a lymphocyte homing receptor reveals a lectin. Cell (1989); 56: 1045–1055
   PubMed Web of Science ®Google Scholar
• Lee Y. C., Townsend R. R., Hardy M. R., Lonngren J., Arnarp J., Haraldsson M., Lonn H. Binding of synthetic oligosaccharides to the hepatic gal / galNac lectin. Dependence on fine structural features. J. Biol. Chem. (1983); 258: 199–202
   PubMed Web of Science ®Google Scholar
• Lee R. T., Lee Y. C. Preparation of cluster glycosides of N-acetylgalactosamine that have subnanomolar binding constants towards the mammalian hepatic Gal/GalNAc-specific receptor. Glycoconjugate J. (1987); 4: 317–328
   Web of Science ®Google Scholar
• Lee R. T., Lee Y. C. Enhanced Biochemical Affinities of Multivalent Neoglycoconjugates. Neoglycoconjugates: Preparation and Applications, Y. C. Lee, R. T. Lee. Academic Press, San Diego (1994); 23–50
   Google Scholar
• Lee Y. C., Rice K. G. Fractionation of Glycopeptides and Oligosaccharides from Glycoproteins by HPLC. Glycobiology: A Practical Approach, M. Fukuda, A. Kobata. Oxford University Press, Oxford (1994); 127–163
   Google Scholar
• Magnusson G., Chernyak A. Y., Kihlberg J., Kononov L. O. Synthesis of Neoglycoconjugates. Neoglycoconjugates: Preparation and Applications, Y. C. Lee, R. T. Lee. Academic Press, San Diego (1994); 53–143
   Google Scholar
• Manger I. D., Rademacher T. W., Dwek R. A. 1-N-Glycyl β-Oligosaccharide Derivatives as Stable Intermediates for the Formation of Glycoconjugate Probes. Biochemistry (1992); 31: 10724–10732
   PubMed Web of Science ®Google Scholar
• Matthews T. J., Weinhold K. J., Lyerly H. K., Langlios A. J., Wigzell H., Bolognesi D. P. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gpl20 and the surface CD: Role of carbohydrate in binding and cell fusion. Proc. Natl. Acad. Sci. USA (1987); 84: 5424–5428
   PubMed Web of Science ®Google Scholar
• Meijer D. K.F., Jansen R. W., Molema G. Drug targeting for antiviral agents: options and limitations. Antiviral Res. (1992); 18: 215–258
   PubMed Web of Science ®Google Scholar
• Menander-Huber K. B., Huber W. Orgotein, the drug version of bovine Cu-Zn superoxide dismutase. II. A summary of clinical trials in man and animals. Superoxide and Superoxide Dismutases, A. M. Michelson, J. M. McCord, I. Fridovich. Academic Press, London (1977); 537–556
   Google Scholar
• Midoux P., Negre E., Roche A. C., Mayer R., Monsigny M., Balzarini J., De Clercq E., Mayer E., Ghaffar A., Gangemi J. D. Drug targeting: anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)-adenine. Biochem. Biophys. Res. Comm. (1990); 167: 1044–1049
   PubMed Web of Science ®Google Scholar
• Midoux P., Mendes C., Legrand A., Raimond J., Mayer R., Monsigny M., Roche A. C. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res. (1993); 21: 871–878
   PubMed Web of Science ®Google Scholar
• Miller A. D. Human gene therapy comes of age. Nature (1992); 357: 455–460
   PubMed Web of Science ®Google Scholar
• Molema G., Jansen R. W., Pauwels R., De Clercq E., Meijer D. K.F. Targeting of antiviral drugs to T4-lymphocytes: anti-HIV activity of neoglycoprotein-AZTMP conjugates in vitro. Biochem. Pharmacol (1990); 40: 2603–2610
   PubMed Web of Science ®Google Scholar
• Molema G., Jansen R. W., Visser J., Herdewijn P., Moolenaar F., Meijer D. K.F. Neoglycoproteins as carriers for antiviral drugs: synthesis and analysis of protein-drug conjugates. J. Med. Chem. (1991); 34: 1137–1141
   PubMed Web of Science ®Google Scholar
• Molema G., Meijer D. K.F. Targeting of drugs to various blood cell types using (neo-)glycoproteins, antibodies and other protein carriers. Advanced Drug Delivery Rev. (1994); 14: 25–50
   Web of Science ®Google Scholar
• Monsigny M., Roche A. C., Bailly P. Tumoricidal activation of murine alveolar macrophages by muramyldipeptide substituted mannosylated serum albumin. Biochem. Biophys. Res. Comm. (1984); 121: 579–584
   PubMed Web of Science ®Google Scholar
• Monsigny M., Roche A. C., Midoux P. Endogenous lectins and drug targeting. Ann. N.Y. Acad. Sci. (1988a); 551: 399–414
   PubMed Web of Science ®Google Scholar
• Monsigny M., Roche A. C., Kieda C., Midoux P., Obrenovitch A. Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells. Biochimie (1988b); 70: 1633–1649
   PubMed Web of Science ®Google Scholar
• Monsigny M., Roche A. C., Midoux P., Mayer R. Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes. Advanced Drug Delivery Rev. (1994); 14: 1–24
   Web of Science ®Google Scholar
• Moonis M., Ahmad I., Bachhawat B. K. Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice. J. Drug Targeting (1993); 1: 147–155
   PubMed Web of Science ®Google Scholar
• Morgan R. A., Anderson W. F. Human gene therapy. Annu. Rev. Biochem. (1993); 62: 191–217
   PubMed Web of Science ®Google Scholar
• Moscicki R. A., Taunton-Rigby A. Treatment of Gaucher's disease. New Engl. J. Med. (1993); 328: 1564
   PubMedGoogle Scholar
• Mulligan R. C. The basic science of gene therapy. Science (1993); 260: 926–932
   PubMed Web of Science ®Google Scholar
• Murray G. J. Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells. Meth. Enzymol. (1987); 149: 25–42
   PubMed Web of Science ®Google Scholar
• Negre E., Chance M. L., Hanboula S. Y., Monsigny M., Roche A. C., Mayer R. M., Hommel M. Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins. Antimicrobial Agents Chemotherapy (1992); 36: 2228–2232
   PubMed Web of Science ®Google Scholar
• NYT. The world's most expensive drug. New York Times (January 22, 1992); C19
   Google Scholar
• Ohsumi Y., Chen V. J., Wold F., Lee Y. C. Interaction between new neoglycoproteins and the D-Man/L-Fuc receptor of rabbit alveolar macrophages. Glycoconjugate J. (1898); 5: 99–106
   Google Scholar
• Pak C. C., Fidler I. J. Molecular mechanisms for activated macrophage recognition of tumor cells. Seminars Cancer Biology (1991); 2: 189–195
   PubMedGoogle Scholar
• Parant M. Biological properties of a new synthetic adjuvant, muramyl dipeptide (MDP). Springer Semin. Immunopathol (1979); 2: 101–118
   Web of Science ®Google Scholar
• Perales J. C., Ferkol T., Beegen H., Ratnoff O. D., Hanson R. W. Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc. Natl. Acad. Sci. (1994); 91: 4086–4090
   PubMed Web of Science ®Google Scholar
• Petit C., Monsigny M., Roche A. C. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers; cytotoxic factor production. J. Biol. Response Modifiers (1990); 9: 33–43
   PubMedGoogle Scholar
• Pietersz G. A. The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer. Bioconjugate Chem. (1990); 1: 89–95
   PubMed Web of Science ®Google Scholar
• Pimm M. V. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations. CRC Crit. Rev. Therap. Drug Carrier Sys. (1988); 5: 189–227
   PubMed Web of Science ®Google Scholar
• Pimm M. V., Perkins A. C., Duncan R., Ulbrich K. Targeting of N-(2-hydroxypropyl)methacrylamide coplymerdoxorubicin conjugate to the hepatocyte galactose-receptor in mice: Visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies. J. Drug Targeting (1993); 1: 125–131
   PubMed Web of Science ®Google Scholar
• Plank C., Zatloukal K., Cotten M., Mechtler K., Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem. (1992); 3: 533–539
   PubMed Web of Science ®Google Scholar
• Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. (1994); 269: 12918–12924
   PubMed Web of Science ®Google Scholar
• Ponzetto A., Fiume L., Forzani B., Song S. Y., Busi C., Mattioli A., Spinelli C., Marinelli M., Smedile A., Chiaberge E., Bonino F., Gervasi G. B., Rapicetta M., Verme G. Adenine arabinoside monophosphate and acyclovir monophosphate coupled to lactosaminated albumin reduce woodchuck virus viremia at doses lower than do the unconjugated drugs. Hepatology (1991); 14: 16–24
   PubMed Web of Science ®Google Scholar
• Poznansky M. J., Juliano R. L. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev. (1984); 36: 277–336
   PubMed Web of Science ®Google Scholar
• Reinis M., Damkova M., Korec E. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. J. Virol. Meth. (1993); 42: 99–106
   PubMed Web of Science ®Google Scholar
• Rejmanova P., Kopecek J., Duncan R., Lloyd J. R. Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers. Biomaterials (1985); 6: 45–48
   PubMed Web of Science ®Google Scholar
• Rice K. G., Weisz O. A., Barthel T., Lee R. T., Lee Y. C. Defined geometry of binding between triantennary glycopeptide and asialoglycoprotein receptor of rat hepatocytes. J. Biol. Chem. (1990); 265: 18429–18434
   PubMed Web of Science ®Google Scholar
• Roche A. C., Bailly F., Monsigny M. Macrophage activation by MDP bound to neoglycoproteins: metastasis eradication in mice. Invasion Metastasis (1985); 5: 218–232
   PubMedGoogle Scholar
• Roche A. C., Midoux P., Pimpaneau V., Negre E., Mayer R., Monsigny M. Endocytosis mediated by monocyte and macrophage membrane lectins-application to antiviral drug targeting. Res. Virol (1990); 141: 243–249
   PubMedGoogle Scholar
• Roemer K., Friedmann T. Concepts and strategies for human gene therapy. Eur. J. Biochem. (1992); 208: 211–225
   PubMedGoogle Scholar
• Rothenberg B. E., Hayes B. K., Toomre D., Manzi A. E., Varki A. Biotinylated diaminopyridine: an approach to tagging oligosaccharides and exploring their biology. Proc. Natl. Acad. Sci. USA (1993); 90: 11939–11943
   PubMed Web of Science ®Google Scholar
• Ryman B. E., Tyrrell D. A. Liposomes-bags of potential. Essays Biochem. (1980); 16: 49–98
   PubMedGoogle Scholar
• Schwartz A. L. The hepatic asialoglycoprotein receptor. CRC Crit. Rev. Biochem. (1984); 16: 207–233
   PubMed Web of Science ®Google Scholar
• Sett R., Sarkar K., Das P. K. Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin. J. Antimicrobial Chemotherapy (1993a); 31: 151–159
   PubMed Web of Science ®Google Scholar
• Sett R., Sarkar K., Das P. K. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease. J. Infectious Diseases (1993b); 168: 994–999
   PubMed Web of Science ®Google Scholar
• Seymour L. W., Ulbrich K., Wedge S. R., Hume I. C., Strohalm J., Duncan R. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2mice. Br. J. Cancer (1991); 63: 859–866
   PubMed Web of Science ®Google Scholar
• Seymour L. W. Soluble polymers for lectin-mediated drug-targeting. Advanced Drug Delivery Rev. (1994); 14: 89–111
   Web of Science ®Google Scholar
• Shen W. C., Ryser J. P. Cis-aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem. Biophys. Res. Commun. (1981); 102: 1048–1054
   Google Scholar
• Shen T. Y. Saccharide determinants in selective drug delivery. Ann. N.Y. Acad. Sci. (1987); 507: 272–280
   PubMed Web of Science ®Google Scholar
• Spellman N. W. Carbohydrate characterization of recombinant glycoproteins of pharmaceutical interest. Anal. Chem. (1990); 62: 1714–1722
   PubMed Web of Science ®Google Scholar
• Spiess M., Schwartz A. L., Lodish H. F. Sequence of human asialoglycoprotein receptor cDNA. J. Biol. Chem. (1985); 260: 1979–1982
   PubMed Web of Science ®Google Scholar
• Stahl P. D., Rodman J. S., Miller M. J., Schlesinger P. H. Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc. Natl. Acad. Sci. (1978); 75: 1399–1403
   PubMed Web of Science ®Google Scholar
• Stahl P. D., Wileman T. E., Diment S., Shepherd V. L. Mannose-specific oligosaccharide recognition by mononuclear phagocytes. Biol. Cell. (1984); 51: 215–218
   PubMed Web of Science ®Google Scholar
• Stein C. A., Cheng Y. C. Antisense oligonucleotides as therapeutic agents-is the bullet really magical?. Science (1993); 261: 1004–1012
   PubMed Web of Science ®Google Scholar
• Stowell C. P., Lee Y. C. Neoglycoproteins. The preparation and application of synthetic glycoproteins. Adv. Carbohydrate Chem. Biochem. (1980); 37: 225–281
   PubMedGoogle Scholar
• Sullivan M. S., Connor J., Huang L. Immunoliposomes: preparation, properties, and applications. Medicinal Res. Rev. (1986); 6: 171–195
   PubMed Web of Science ®Google Scholar
• Szoka F. C. The future of liposomal drug delivery. Biotechnology & Applied Biochemistry (1990); 12: 496–500
   PubMed Web of Science ®Google Scholar
• Tabata Y., Ikada Y. Drug delivery systems for antitumor activation of macrophages. Crit. Rev. Ther. Drug Carrier Syst. (1990); 7: 121–148
   PubMed Web of Science ®Google Scholar
• Takakura Y., Masuda S., Tokuda H., Nishikawa M., Hashida M. Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism. Biochem. Pharmacol. (1994); 47: 853–858
   PubMed Web of Science ®Google Scholar
• Tamura T., Wadhwa M. S., Rice K. G. Reducing-end modification of N-linked oligosaccharides with tyrosine. Anal. Biochem. (1994); 216: 335–344
   PubMed Web of Science ®Google Scholar
• Taylor M. E., Bezouska K., Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J. Biol. Chem. (1992); 267: 1719–1726
   PubMed Web of Science ®Google Scholar
• Torchilin V. P. Liposomes as targetable drug carriers. CRC Crit Rev Ther Drug Carrier Syst. (1985); 2: 65–115
   PubMedGoogle Scholar
• Trouet A., Masqueller M., Baurain R., Campeneere D. D. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies. Proc. Natl. Acad. Sci. (1982); 79: 626–629
   PubMed Web of Science ®Google Scholar
• Umezawa F., Eto Y. Liposome targeting to mouse brain: mannose as a recognition marker. Biochem. Biophys. Res. Comm. (1988); 153: 1038–1044
   PubMed Web of Science ®Google Scholar
• Vaickus L., Foon K. A. Overview of monoclonal antibodies in the diagnosis and therapy of cancer. Cancer Invest. (1991); 9: 195–209
   PubMed Web of Science ®Google Scholar
• Van Berkel T. J.C., Kar Kruijt J., Spanjer H. H., Nagelkerke J. F., Harkes L., Kempen H. J. The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J. Biol. Chem. (1985a); 260: 2694–2699
   PubMed Web of Science ®Google Scholar
• Van Berkel X. J.C., Kar Kruijt J., Kempen H. J. Specific targeting of high density lipoproteins to liver hepatocytes by incorporation of a tris-galactoside-terminated cholesterol derivative. J. Biol. Chem. (1985b); 260: 12203–12207
   PubMedGoogle Scholar
• Van Den Hamer C. J., Morell A. G., Scheinberg I. H., Hickman J., Ashwell G. Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. J. Biol. Chem. (1970); 245: 4397–4402
   PubMed Web of Science ®Google Scholar
• Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology (1993); 3: 97–130
   PubMed Web of Science ®Google Scholar
• Venter J. C. Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applications. Pharmacol. Rev. (1982); 34: 153–187
   PubMed Web of Science ®Google Scholar
• Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M. L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA (1990); 87: 3410–3414
   PubMed Web of Science ®Google Scholar
• Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D. T., Birnstiel M. L. Coupling of adenovirus to transferrin-polylysine / DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA (1992a); 89: 6099–6103
   PubMed Web of Science ®Google Scholar
• Wagner E., Plank C., Zatloukal K., Cotten M., Birnstiel M. L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA (1992b); 89: 7934–7938
   PubMed Web of Science ®Google Scholar
• Wang J. L., Laing J. G., Anderson R. L. Lectins in the cell nucleus. Glycobiology (1991); 1: 243–252
   PubMedGoogle Scholar
• Whiteworth P. W., Pak C. C., Esgro J., Kleinerman E. S., Fidler I. J. Macrophages and cancer. Cancer Metastasis Reviews (1990); 8: 319–351
   PubMed Web of Science ®Google Scholar
• Wileman T., Harding C., Stahl P. Receptor mediated endocytosis. Biochemical J. (1985); 232: 1–14
   PubMed Web of Science ®Google Scholar
• Wilson J. M., Grossman M., Wu C. H., Chowdhury N. R., Wu G. Y., Chowdhury J. R. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J. Biol. Chem. (1992a); 267: 963–967
   PubMed Web of Science ®Google Scholar
• Wilson J. M., Grossman M., Cabrera J. A., Wu C. H., Wu G. Y. A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes. J. Biol. Chem. (1992b); 267: 11483–11489
   PubMed Web of Science ®Google Scholar
• Wood S. J., Wetzel R. A novel method for the incorporation of glycoprotein-derived oligosaccharides into neoglycoproteins. Bioconjugate Chem. (1992); 3: 391–396
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Wu C. H. Evidence for targeted gene delivery to HepG2 hepatoma cells in vitro. Biochemistry (1988a); 27: 887–892
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Wu C. H. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. (1988b); 263: 14621–14624
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Keegan-Rogers V., Franklin S., Midford S., Wu C. H. Targeted antagonism of galactosamine toxicity in normal rat hepatocytes in vitro. J. Biol. Chem. (1988c); 263: 4719–4723
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Wilson J. M., Shalaby F., Grossman M., Shafritz D., Wu C. H. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in nagase rats. J. Biol. Chem. (1991); 266: 14338–14342
   PubMed Web of Science ®Google Scholar
• Wu G. Y., Wu C. H. Specific inhibition of hepatitis B viral gene expression in vitro by oligonucleotides. J. Biol. Chem. (1992); 267: 12436–12439
   PubMed Web of Science ®Google Scholar
• Yamazaki N., Kojima S., Gabius S., Gabius H. J. Studies on carbohydrate-binding proteins using liposome-based systems-I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices. Int. J. Biochemistry (1992); 24: 99–104
   PubMedGoogle Scholar
• Zon G. Oligonucleotide analogues as potential chemotherapeutic agents. Pharm. Res. (1988); 5: 539–549
   PubMed Web of Science ®Google Scholar